Home/Filings/4/0001104659-24-006401
4//SEC Filing

Kalin Katherine Bach 4

Accession 0001104659-24-006401

CIK 0001390478other

Filed

Jan 24, 7:00 PM ET

Accepted

Jan 25, 6:03 AM ET

Size

7.7 KB

Accession

0001104659-24-006401

Insider Transaction Report

Form 4
Period: 2024-01-22
Transactions
  • Award

    Stock Option (Right to Buy)

    2024-01-22+10,00010,000 total
    Exercise: $0.52Exp: 2034-01-22Common Stock (10,000 underlying)
  • Award

    Common Stock

    2024-01-22+6,0008,500 total
Footnotes (2)
  • [F1]The Reporting Person received an award of 6,000 restricted stock units on January 22, 2024, which shall vest in full on December 1, 2024, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such date.
  • [F2]The shares subject to the option will fully vest on the earlier of (x) January 22, 2025 (the first anniversary of the date of grant) or (y) the business day prior to the 2025 annual stockholders meeting, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such date.

Issuer

SELLAS Life Sciences Group, Inc.

CIK 0001390478

Entity typeother

Related Parties

1
  • filerCIK 0001832671

Filing Metadata

Form type
4
Filed
Jan 24, 7:00 PM ET
Accepted
Jan 25, 6:03 AM ET
Size
7.7 KB